HOUSTON, July 18, 2017 -- Frank’s International N.V. (the “Company”) (NYSE:FI) announced today that it will host a conference call to discuss its second quarter 2017 results on Monday, August 7, 2017 at 10:00 a.m. Central Time (11:00 a.m. Eastern Time). The Company will issue its second quarter 2017 earnings release prior to the conference call.
Participants may join the conference call by dialing (888) 771-4371 or (847) 585-4405. The conference call ID number is 45310781. To listen via live webcast, please visit the Investor Relations section of the Company's website, www.franksinternational.com.
An audio replay of the conference call will be available approximately two hours after the conclusion of the call. The audio replay will remain available for seven days by dialing (888) 843-7419 or (630) 652-3042. The conference call audio replay access code is 45310781#. The audio replay will also be available in the Investor Relations section of the Company’s website approximately two hours after the conclusion of the call and remain available for a period of approximately 90 days.
Frank’s International N.V. is a global oil services company that provides a broad and comprehensive range of highly engineered tubular running services, tubular fabrication, and specialty well construction and well intervention solutions with a focus on complex and technically demanding wells. Founded in 1938, Frank’s has approximately 3,000 employees and provides services to leading exploration and production companies in both onshore and offshore environments in approximately 60 countries on six continents. The Company’s common stock is traded on the NYSE under the symbol “FI.” Additional information is available on the Company’s website, www.franksinternational.com.
Frank’s International uses its website as a channel of distribution of material company information. Such information is routinely posted and accessible in the Investor Relations section of our website at www.franksinternational.com.
Contact: Blake Holcomb – Director, Communications & Investor Relations [email protected] 713-231-2463


FDA Approves Mitapivat for Anemia in Thalassemia Patients
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Italy Fines Apple €98.6 Million Over App Store Dominance
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 



